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Abstract
Inflammation is the main key role in developing chronic diseases including cancer, cardiovascular diseases, diabetes,
arthritis, and neurodegenerative diseases which possess a huge challenge for treatment. With massively compelling
evidence of the role played by nutritional modulation in preventing inflammation-related diseases, there is a growing
interest into the search for natural functional foods with therapeutic and preventive actions. Honey, a nutritional healthy
product, is produced mainly by two types of bees: honeybee and stingless bee. Since both types of honey possess
distinctive phenolic and flavonoid compounds, there is recently an intensive interest in their biological and clinical actions
against inflammation-mediated chronic diseases. This review shed the light specifically on the bioavailability and
bioaccessibility of honey polyphenols and highlight their roles in targeting inflammatory pathways in gastrointestinal tract
disorders, edema, cancer, metabolic and cardiovascular diseases and gut microbiota.
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Background
Honeybees which are named in Latin as Apis, use the
collected nectar from plants to produce honey after re-
gurgitation and digestion of nectar. Several biological
compounds from honeybees are added during honey for-
mation. Honeybees store honey to be used during win-
ter. Their wings fan the honey to evaporate the water
content in nectar to avoid fermentation of honey. Honey
has been used to treat a variety of ailments such as gas-
tric disturbance, skin burn and ulcers [1]. Currently, two
types of honey are produced globally: traditional Apis
mellifera honey and stingless bee honey. Honey has been
reported to have healthy benefits which are antioxidant
[2], anti-proliferative [3], and anti-bacterial [4]. The pur-
pose of this review is to summarize another aspect of
the honey’s health benefit which is the anti-
inflammatory studies of honey underlying the possible
mechanisms involved in the response to honey supple-
mentation on inflammation-mediated chronic diseases
as proposed by a wide collection of scientific papers in
the literature.
Honey composition
Honey contains macro and micronutrients which de-
pends basically on various factors: 1) bee type, 2) floral
source, and 3) environmental and processing factors. In
general, there are approximately 200 compounds in
honey such as sugar, protein, enzymes, minerals, vita-
mins, amino acid, and a wide range of polyphenols. The
variety ratio of these compounds results in different
color, taste, viscosity, and therapeutic activities of each
honey. In this sense, the combination of all these com-
pounds perform synergistically in different aspect of ap-
plications [5]. Most of the honeys over the world share
80% of the physical properties and chemical compos-
ition. Based on that, various methods have been devel-
oped to discriminate the entomological origins of honey
and other factors using nuclear magnetic resonance [6].
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The previous techniques provide the literature with spe-
cific results related to the differences in composition be-
tween Apis mellifera honey and stingless bee honeys.
Macronutrients of honey
The macronutrient composition of honey as shown in
Fig. 1 represents an interesting source of carbohydrates
which is the main core of honey and support the anti-
spoilage properties. The carbohydrate ratio is ranged
from 60 to 95% of its dry weight including mono-, di-
and tri-saccharides where floral type is a key factor in
modulating this ratio [7]. More than 20 types of carbo-
hydrates have been identified in honeys samples from
different part of the world [8]. The principal carbohy-
drate existed is fructose followed by glucose with 28–
40% and 20–35%, respectively, while the disaccharide
and trisaccharide concentration are around 5 and 1%, re-
spectively [9]. The most identified disaccharides are mal-
tose, maltulose, turanose, sucrose, nigerose whereas a
few trisaccharide such as erlose, centose, isomaltotrios,
panose, psopanose and ketose are found in small
amount [10].
The protein content of honey is roughly ranged from
0.2–0.5% in forms of enzymes and free amino acids.
Generally, the total amount of free amino acid in honey
range approximately between 10 and 200mg/100 g
honey and proline contribute with 50% of total amino
acid [11]. G-aminobutyric acid and ornithine have been
identified in honey samples in addition to b-alanine and
a-alanine [12]. While the main source of protein and
amino acid is pollen, honeybee contribute to modifying
this profile through regurgitation. Defensin-1 protein
has been found in bee hemolymph and subsequently in
different honey samples except Manuka honey [13].
Lipids quantity in most of honey samples is negligible
about 0.002%. Plants and wax take part primarily in the
exitance of various lipids compounds in form of acids
such as palmitic, oleic, miristic, and linoleic acid [14].
Micronutrients of honey
The minerals and vitamins profile in honey are varied
according to floral type and geographic origin, represent-
ing from 0.2–0.5% of honey dry weight. Although essen-
tial minerals and elements are trace in honey, human
body need them to perform the several biological actions
perfectly [15]. Several studies have been conducted to
determine the minerals content in honey samples over
the world in order to reveal the existence of contamin-
ant minerals [16, 17]. Potassium and sodium constitute
mostly 80% of total minerals while iron, copper and
manganese are rare in quantity. Moreover, trace ele-
ments have been recruited recently for identification
purposes of different unifloral honeys [18]. To illustrate
more, the presence mixture of potassium, cadmium, and
nickel was implemented as a strong indicator to distin-
guish honeydew honey while barium and lead were spe-
cific components of rape honeys [19]. With respect to
vitamins, one study has found thiamin, riboflavin, pyri-
doxin, niacin and ascorbic acid in several honey samples,
however, their amount do not correspond with the rec-
ommended daily intake of human [20]. The lipids and
fat-soluble vitamins content in honey are hard to detect.
Enzymes in honey
Unlike other sweetening agents, honey contain various
active enzymes that play key role in its biological func-
tion. The source of these enzymes is probably from nec-
tar, bee, or micro-organisms in honey [21]. Invertase,
glucose oxidase, and diastase are the main enzymes in
honey. Although invertase is involved in catalyzing su-
crose into its constituent in honey, small amount of su-
crose is still present in the final stage of honey ripening
[22]. Diastase’s function is to breakdown the chemical
bonds in starch and mainly in maltose, even though
starch is not detected in any honey samples. Thus, the
original function of diastase in honey remain unclear,
however, few methods have developed to measure dia-
stase as a quality indicator of honey, where the quality of
honey is positively proportional to diastase amount [7,
22]. Glucose oxidase is one of carbohydrate metabolizing
enzymes. The nativity of glucose oxidase is the
pharyngeal glands of bee and thus its amount is varied.
Glucose oxidase breakdown glucose into gluconic acid,
which is one of the importance honey acids, and hydro-
gen peroxidase. The presence of glucose oxidase has pre-
vented the microbial growth in honey [23]. However,
Fig. 1 Pie-chart of honey composition demonstrating the percentage of
carbohydrates which is almost 80% while water is around 17%. Other
components such as enzymes, proteins, vitamins and polyphenols
represent 3.24%. The numbers shown in pie-chart are varied in each type
of honey
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glucose oxidase could be affected by many factors which
explain, in part, of its absence in various types of honey
samples [13].
Bioaccessibility and bioavailability of honey polyphenols
The presence of polyphenol in honey is believed to be
from the plant’s nectar while polyphenols quality and
quantity depend on the geographical region, floral
source, climatic conditions, and bee type [7]. Therefore,
one study has suggested that polyphenol profile of honey
could be as a floral marker to verify the botanical origin
[24]. The attempts to identify the phenolic profile of
honey samples have been noticed in many food analyt-
ical studies [2, 25]. Most of these studies have utilized
mainly HPLC-UV and HPLC-DAD for quantification
and identification purposes with various modified
methods. However, LC-MS/MS has been concluded to
be more accurate than LC-MS, while GC-MS has been
recruited mainly to identify the volatile compounds [26].
Furthermore, the previous mentioned technologies con-
tribute to creating phenolic profiles for many types of
honey despite of the complex chemical structure of
honey. Thus, developing an optimized method to iden-
tify and quantify polyphenols in honey is still required.
The existence of one or more phenolic compounds in
honey samples have been claimed as phytochemical
markers for the floral origin. Founded free in honey
samples, phenolic acids such as p-coumaric, gallic acid,
caffeic acid and ferulic acid were commonly identified in
different floral type of honey [27–29]. However, depend-
ing on few phenolic and flavonoid compounds is not
sufficient to determine the multi-floral origin of honeys
where the same compounds could be existed. To explain
more, the verification of honey floral is undermined by
the concentration and content among polyphenols com-
pounds [30]. Considered as biomarkers for rosemary and
sunflower honeys, quercetin and kaempferol have been
found in high levels of pumpkin, rapeseed, and melon
honeys [31]. Thereby, adding other chemical factors to
verify closely the geographical origin of honey remain
the proper option.
The phenolic content of honey has been correlated
with antioxidant activities in many published researches
[32]. In addition, honey’s phenolic profile reflects the
bees’ type, botanical origin, season, and the region. One
study compares the phenolic content between the com-
mon honeybee and stingless bee honey. The total phen-
olic content of Malaysian stingless bee honey was
approximately 235mg GAE equivalent 100 mg compared
to Tualang honey 183 mg GAE equivalent 100mg, while
the flavonoid content of stingless bee honey was 100 mg
CE equivalent 100 mg. In the same study, the antioxi-
dant results of stingless bee honey were significantly
higher than the normal honey [2]. Likewise, the honey of
stingless bee from Plebia spp. species has higher phen-
olic content than Apis spp. 106.01 ± 9.85 mg GAE
equivalent/100 g compared to Apis spp. 92.34 ± 13.55 mg
GA acid equivalent/100 g, respectively [33]. Further-
more, honey produced from Meliponini, a stingless bee
species, has the highest radical scavenging activity
against ABTS cation due to the high levels of phenolic
and flavonoid contents. Contributing in proinflammatory
state, ROS has been inhibited after treating with honey
extract from stingless bee [34]. In the same study, the
author concluded that the stingless bee honey-rich in
polyphenol had suppressed the infiltration of leukocyte
through downregulating myeloperoxidase and reduced
the ear edema [34]. Previous studies-related to the medi-
cinal value of stingless bee honey indicate that there is a
deep limitation of reported research. The potential
therapeutic value of stingless bee honey is needed to be
widely explored against inflammatory and oxidative
stress related disease. Probably, the phenolic compounds
in stingless bee honey have high pharmacokinetics and
react synergistically in preventing or treating disease.
Since polyphenol compounds have retained a great at-
tention by scientific communities as preventive agents
against degenerative and chronic inflammatory diseases
[35], the main therapeutic activities of honey are attrib-
uted to its content of polyphenols because they are the
most abundant phytochemcials [2, 36]. These activities
are controlled by the bioaccessibility and bioavailability
of polyphenols in human body. In terms of bioaccessibi-
lity, polyphenols which is released from the food matrix
or absorbed by small intestine through mechanical and
biochemical breakdown are potentially bioavailable and
bioactive [37]. However, the molecular interaction of
polyphenols with other food compounds during diges-
tion process may decrease or increase the bioaccessibility
[38, 39]. For example, the bioaccessibility of anthocyanin
has been varied when testing its release from different
foods (whole berries, berry juice, wine, jam, powders)
[40]. The existence of dietary fibers in food matrix play a
major role in releasing polyphenols for absorption into
gastrointestinal tract [37]. Few clinical trials illustrated
that less than 10% of polyphenols (aglycones and gluco-
side conjugate) are being absorbed in the upper gastro-
intestinal tract due to the effect of food matrix, while the
rest of phenolic compounds undergo to microfloral
metabolization at which bioactive metabolites cross co-
lonic mucosa to plasma [37, 41, 42]. At the same time, it
is apparent that polyphenols may have high affinity to
protein and fibers, especially if all the previous compo-
nents are present together. Thus, the presence of poly-
phenol in a food matrix with negligible amounts of
dietary fibers, protein and lipids could reduce the mo-
lecular interactions and may increase the bioaccessibility
and bioavailability ratio in honey. In this sense, the
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phenolic content and antioxidant activity of Manuka
honey were not altered after subjecting to in-vitro diges-
tion process compared with other commercial honey
samples [43]. In addition to that, 1-3 mg/ml of post- and
pre-digested Manuka honey has significantly protective
ability against hydrogen peroxide induced DNA damage
in Caco-2 cell line. This demonstrate that polyphenols in
Manuka honey are not affected by any molecular
changes due to digestion process and thus, they may
have high bioaccessibility ratio [43]. In another study,
adding floral and pine honey to brewed coffee signifi-
cantly increased the levels of phenolic content and anti-
oxidant activities after simulating digestion process
in vitro. The possibilities of using honey as a natural
sweetener synergize the phenolic content of coffee and
consequently, leading to high bioavailability [44]. After
mimicking the gastric and intestinal digestion, the phen-
olic content and antioxidant activities of Turkish honey-
bee pollen have been reduced which could probably due
to either the interaction of polyphenols and protein hon-
eybee pollen matrix or the difference in pH levels which
influence the bioactivity of phenolic compounds. There-
fore, maximizing the effect of honeybee pollen could be
achieved through encapsulation [45]. However, bractinga
honeydew honey has shown different results in terms of
phenolic content and antioxidant capacities where
in vitro duodenal digestion decreases the antioxidant
stability and increase the flavonoid content. The bioac-
cessible fraction was increased from 112% after gastric
ingestion to become 174% after duodenal digestion [46].
Overall, the previous studies have used in vitro model to
mimic digestion process in which honey polyphenols
stability have been examined and demonstrated potential
bioaccessibility and bioavailability. Possibly, this stability
observed in vitro may not be the same as in vivo due to
differences in conditions and concentrations of honey.
Determining the best phenolic compounds in terms of
absorption and producing bioactive metabolites is still
occupying the main objective in bioavailability studies
through which the biological actions of polyphenols
within targeted tissues could be revealed and classified.
As a result of that, bioavailability studies have measured
the phenolic compounds concentrations in plasma and
urinary execration among subjects supplemented with
polyphenols as pure compound, plant extract or whole
food [39, 47]. While polyphenols-derived metabolites, af-
fected by the gastric and hepatic processes, could be in-
active, detecting these metabolites in plasma and urine
requires a rigorous technique. Also, there is a lacking re-
search with respect to the bioavailability of polyphenols
in human. Thus, these challenges could attract researchers
to investigate the pharmacokinetics and pharmacodynam-
ics of honey as rich food in polyphenol. Moreover, human
interventions trials with honey seem to be overpowered.
The phenolic acid and flavonoid in honey are varied with
different bioavailability. In general, phenolic acids ratio are
used to be higher than flavonoid in honey. At the same
time, phenolic acid classes; hydroxycinnamic derivatives
and hydroxybenzoic derivatives are well absorbed in hu-
man body as they are in aglycon form [47]. Gallic, caffeic,
p-coumaric, and sinapic acid have been proven to be well
absorbed in the upper part of gastro-intestinal system des-
pite of the differences in kinetic efficacy [37]. Recently, it
has been indicated that stomach could have an active ab-
sorption site for the above-mentioned phenolic acids [48].
The mechanism of absorption is mediated through mono-
carboxylic acid transporter and paracellular diffusion. On
the other hand, flavonoid absorption in small intestine is
considered as a complex process where flavonoids, in
forms of glycoside, require hydrolysis process to convert
into aglycones. This hydrolytic process is performed
through two enzymes: 1) lactase phlorizin hydrolase acting
in the epithelial cells, 2) cytosolic β-glucosidase in the en-
terocyte. Then, aglycones can be absorbed by the intes-
tinal cells namely, enterocytes crossing to the blood
stream [39, 41, 47]. The existence of glycosidase enzyme
in bee salivary glands contribute essentially to hydrolyzing
glycosylated polyphenols into aglycones form. Therefore,
honey polyphenols which are in aglycones forms, could
have more potential bioavailability than other foods [49].
However, a direct investigation on the bioavailability of
honey polyphenols either in vivo or in human has not
been conducted yet. In contrast, administrating natural
honey as a dietary supplement in various animal and
clinical trials have either improved or ameliorated the
pathological status of studied subjects [1, 50]. Indeed, con-
suming 1.5 g of honey per kilogram of human body has el-
evated the antioxidant status in healthy individuals
comparing with those who have consumed the same
amount of corn syrup [51]. Although the previous study
may promote the pharmacokinetics of honey polyphenols,
the possible action of honey polyphenols in improving the
total antioxidant could be indirectly throughout support-
ing the endogenous antioxidant system. A randomized
clinical trial has revealed the supportive effect of Tualang
honey on glutathione peroxidase, superoxide dismutase
and catalase activities in chronic smokers’ subjects [52].
Although some individuals have differences in the uptake
and metabolism of phytochemical due to polymorphism,
honey intervention trials demonstrate that the variability
in the level of honey polyphenols absorption could be low
[53]. Hence, determining the bioavailability of honey poly-
phenols in tissues is crucial to confirm the percentage of
absorption. The conjugation reaction of polyphenols in
hepatic tissues to detoxify potential toxicity and increase
hydrophilicity is thought to impair the bioactivities of
polyphenols through glucorination, methylation, and sul-
fation. In blood circulating, polyphenols metabolites
Ranneh et al. BMC Complementary Medicine and Therapies           (2021) 21:30 Page 4 of 17
concentration has been found mostly in nanomolar and
micromolar range [39, 54]. Also, determining pharmaco-
kinetics of phenolic compounds have been selectively per-
formed on few types of phenolic compounds, due to the
large number of polyphenols which are eight thousand.
Despite of being proven to have a low plasma concentra-
tion of some phenolic acid and flavonoid, the other phen-
olic compounds could be different. It is noteworthy that
the physiochemical profile of polyphenols (molecular size,
basic structure, degree of polymerization, solubility, conju-
gation with other compounds) contribute essentially in
absorption and metabolism process and consequently,
affect their biomolecular interaction [39]. In terms of
honey, conceivable hypothetical explanations could inter-
pret the positive effect on human intervention studies i)
honey polyphenols absorbed slowly through gastrointes-
tinal tract, ii) the simplicity of honey structure, iii) poly-
phenols metabolized completely in the tissues, iv)
unknown phenolic compounds and/or their metabolites
in honey could have high bioavailability and penetrate
cells with special receptors, v) the absence of anti-
nutrients compounds. In conclusion, bioaccessibility and
bioavailability of honey polyphenols are affected by several
factors such as floral origin, food matrix, gastrointestinal
absorption, liver and intestinal metabolic process, binding
to albumin, tissue accumulation and execration. Hence,
assimilating these factors and attributing them to the
healthy pleiotropic effects are a big challenge. Addition-
ally, reconstructing instrumental analytical equipment
with advanced selectivity and sensitivity is a required step
to understand the pharmacokinetics and pharmaco-
dynamics of honey polyphenols. But at the same time, the
empirical evidence of honey intervention on direct inter-
action with DNA and gene expression have been revealed
[55, 56]. The study to identify potential molecular mecha-
nisms involved in the cellular interactions by various types
of honey polyphenols with its relevant gene expression
profiles should be extensively made.
Inflammation
Inflammation is the natural innate response of immunity
system to pathogens where various cellular and humoral
immune are developed [57]. At the same time, oxidative
stress is present when the balance remains in favor of
the overproduction of free radicals over the antioxidant
components. Inflammation and oxidative stress are asso-
ciated with each other via multiple signaling pathways
[58, 59]. Reactive oxygen species (ROS) produced from
mitochondria, trigger various transcription factors (NF-
κB, ERK, P38, JNK, MAPK) related to producing pro-in-
flammatory cytokines and mediators. Likewise, few cyto-
kines namely, TNF-α and IL-1β can induce the production
of ROS from mitochondria [60, 61]. This correlation rela-
tionship between ROS and pro-inflammatory cytokines
results in metabolic and cellular modifications [62]. In other
words, the onset of uncontrolled inflammatory process
along with the presence of oxidative stress plays a key role
in the pathophysiological incidences of chronic disorders
such as, psychiatric, cardiovascular, traumatic, metabolic,
and autoimmune maladies. Recently, there is growing evi-
dence indicating that honey could have inhibitory effect on
chronic inflammation, oxidative stress and on their relative
gene expression [63]. Also, a group of transcription factors
such as Nrf2, ERK1/2, NF-κB, c-Jun and AP-1 have been
implicated. These transcription factors are responsible for
numerous biological process, primarily production of anti-
oxidant compounds and inflammatory cytokines [64–66].
Synthetic drugs have been developed as agonists to ameli-
orate cancer, ageing process, and CVDs [67, 68]. It has been
suggested that honey compounds including polyphenols
could act as agonists for NF-κB receptors and Toll-Like 4
receptor that are involved in the initiation of inflammation
and oxidative stress.
Potential health benefits of honey against
inflammation
Innate immunity relies strongly on inflammation
which is defined generally as the natural response to
cellular injury. The biological changes are 1) increased
blood flow and capillary distillation, 2) leukocyte infil-
tration, and 3) releasing localized chemoattractants to
recruiter immunity cells. The main objectives of these
changes are to eliminate the pathogen agents and re-
pair the damage tissue [69]. However, non-resolving
inflammation as result of chronic bacterial infection
(LPS infusion) or obesity or aging paves the onset of
low-grade chronic inflammation which subsequently
develop various chronic diseases. In this context, sup-
porting the consumption of natural products in favor
of resolving inflammation and supporting hemostasis
is the main reason for examining these products on
numerous trials. Honey has been suggested as an
immune-modulatory agent with dual role: (1) anti-
inflammatory activities through downregulating the
inflammatory transcription factors (NF-κB and
MAPK) and/or suppressing the production of pro-
inflammatory cytokines, and (2) stimulate the produc-
tion of inflammatory mediators such as prostaglandin
E2 (PGE2) and cyclooxygenase-2 (COX-2) [68]. Vari-
ous models of inflammation treated with honey have
been studied to explain the honey bioactivities to-
wards inflammation (Table 1). Figure 2 represent the
schematic diagram on the inhibition of honey on vari-
ous reactions in the inflammatory process.
Inflammatory disorders of the gastrointestinal tract
Gastrointestinal tract depends on various integrated
factors that work coherently to maintain the hemostasis
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Table 1 In vivo and in vitro studies on the effect of different types of honey
Effect of honey in in vivo study
A combination of insulin and honey This combination inhibited neuronal cell death in different hippocampal areas
of streptozotocin-induced diabetic rats [56].
Alimento Supervis and Alimento Mieleucalipto, which are derived
from chestnut honey
Oral pretreatment (2 g/kg), once daily for 7 consecutive days, prevented
indomethacin-induced gastric lesions in rats by reducing the ulcer index,
microvascular permeability, and myeloperoxidase activity of the stomach [70].
Tualang honey (TH) TH has almost the equal effects when compared with the conventional
treatment in treating alkali injury on rabbit’s eye based on no significant
difference in the level of total antioxidant status as well as lipid peroxidation
products in aqueous humour, vitreous humour and serum between honey
treated and the conventional treated group [71].
Manuka honey (MH) MH significantly increase enzymatic (GPx and SOD), nonenzymatic (GSH)
antioxidants levels and anti-inflammatory cytokine IL-10 levels. It normalized
cell cycle distribution and significantly lowered apoptosis in gastric mucosa
[72].
Honey Intrarectal honey administration is as effective as prednisolone treatment in an
inflammatory model of colitis [73].
Honey Honey prevented gastric mucosal lesions induced by ethanol, indomethacin,
and acidified ASA. The protection was almost total when using ethanol or
acidified ASA as a damaging agent; whereas protection against indomethacin
was moderate [74].
Honey Honey significantly increased CAT, GR, TAS, TGSH, GSH and GSH:GSSG ratio
and significantly reduced activities of SOD and GPx, MDA levels and FPG in
diabetic rats [75].
Melipona marginata honey (MMH) MMH reduced ear edema and reactive oxygen species production. It also
decreased the myeloperoxidase activity [34].
Honey Honey suppressed the phosphorylation of NFkB in cisplatin-induced kidney
dysfunction [76].
Honey There was almost 100% protection against gastric damage with the highest
dose (5 g/kg) of honey used. However, there was only partial protection (58%)
against ethanol-induced gastric lesions [77].
Honey Honey significantly increased high density lipoprotein (HDL) cholesterol while
it significantly reduced hyperglycemia, triglycerides (TGs), very low-density
lipoprotein (VLDL) cholesterol, non-HDL cholesterol, coronary risk index (CRI)
and cardiovascular risk index (CVRI). It also significantly reduced TGs and VLDL
cholesterol [78].
Tualang honey (TH) TH significantly reduced blood glucose levels compared to the diabetic
control rats’ group. It significantly reduced elevated MDA levels and restored
SOD and CAT activities [79].
Gelam honey (GH) GH gave its anti-inflammatory effects by reducing the rat paw edema size and
inhibiting the production of proinflammatory mediators NO, PGE2, TNF-α, and
IL-6 in plasma, and suppress the expression of iNOS, COX-2, TNF-α, and IL-6 in
paw tissue [80].
Gelam honey (GH) GH exhibited its inhibitory effects by attenuating NF-kB translocation to the
nucleus and inhibiting IkBa degradation, with subsequent decrease of inflam-
matory mediators COX-2 and TNF-a [55]
Mad honey or rhododendron honey It significantly lowered MDA levels and TNF-α and MMP-9 expression, and in-
creased antioxidant enzyme activities and IL-10 expression in male Wistar al-
bino rats with streptozotocin-induced diabetes mellitus [81]
Honeybee venom (HBV) Low doses of HBV have been shown to treat RA with anti-inflammatory and
antioxidant effects, by preventing DNA damage. After low-doses of HBV treat-
ment IL-1β, IL-6, TNF-α, TGF-β1, TOS, OSI, MPO and MNL-DNA damage levels
significantly decreased according to the PC, while IFN-γ and TAS levels in-
creased [82].
Trihoney (a combination of three types of natural honey namely:
Trigona, mellifera, and Dorsata)
It significantly lowered serum IL-1β and IL-6 compared to the high cholesterol
diet group of male New Zealand white rabbits and resulted in significant re-
duction of serum TNF-α compared to high cholesterol diet group [83].
Honey It inhibited edema and pain in inflammatory tissues as well as showing potent
inhibitory activities against NO and PGE2 in both non-immune inflammatory
and nociceptive model, and lipopolysaccharide (LPS) in the immune
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Table 1 In vivo and in vitro studies on the effect of different types of honey (Continued)
inflammatory model [84].
Manuka Honey (MH) In inflammatory model of colitis, oral administration of MH (5 g/kg) and
combination with sulfasalazine (360 mg/kg) with MH (5 g/kg) significantly
reduced the colonic inflammation [85].
Honey Honey-treated in dextran sodium sulphate-induced colitis group significantly
exhibited the down-regulation of oxidative, inflammatory, and apoptotic
markers (interleukin-1β and − 6, superoxide dismutase, reduced glutathione,
tumour necrosis factor-α, NO synthase, caspase-3, CD34, Ki67, S100, c-kit, and
neuron-specific enolase) [86].
Effect of honey in in vitro study
A combination of Gelam honey and ginger extract modulate Ras/ERK and PI3K/AKT pathway genes, upregulate caspase 9 and IκB
genes accompanied by downregulation of the KRAS, ERK, AKT, Bcl-xL, NFkB
(p65) genes in a synergistic manner in colon cancer HT29 cells [87].
A combination of Bee honey (BH) and Nigella sativa (NS) significantly decrease in both the number of viable HepG2 cells and the levels
of nitric oxide on one hand, but improvement of the total antioxidant status
and caspase-3 activity [88].
Manuka honey (MH) MH protected mitochondrial functionality, promoted cell proliferation, and
activated the AMPK/Nrf2/ARE signaling pathway, expression of the antioxidant
enzymes SOD and CAT in Primary Human Dermal Fibroblasts (HDFa) [89].
Stingless bee honey Two out of eight stingless bee honey types (Meliponinae) from southern Brazil
increase the secretion of anti-inflammatory cytokine (interleukin-10) in RAW
264.7 macrophages [90].
Kelulut honey at a concentration of 1%; v/v significantly inhibited nitric oxide (NO)
production in LPS-induced RAW 264.7 cells compared to control cells [91].
Tualang honey inhibited UVB-induced DNA damage, and enhanced repair of UVB-mediated
formation of cyclobutane pyrimidine dimers and 8-oxo-7,8-dihydro-2′-deoxy-
guanosine, inhibited UVB-induced nuclear translocation of NF-κB and degrad-
ation of IκBα in murine keratinocyte cell line, inhibited UVB-induced
inflammatory cytokines and inducible nitric oxide synthase protein expression,
inhibited UVB-induced COX-2 expression and PGE2 production [92].
Manuka honey (MH) MH protected mouse RAW-264.7 macrophages against LPS-induced inflamma-
tion, by improving viability, promoting proliferation, reducing apoptosis, and
enhancing energetic metabolism. These effects were linked to the capacity of
MH in modulating the expression of several proteins involved in apoptosis, in-
flammation, metabolism, and mitochondrial biogenesis, such as caspase 3,
p38, pErk1/2, AMPK, SIRT1 and PGC1α [93].
Manuka honey (MH) MH inhibited LPS induced ROS and nitrite accumulation. It suppressed TNF-α,
IL-1β and IL-6, and iNOS [94].
Honey IL-6 secretion was remarkably reduced by all honey varieties in a comparable
level indicating the potential anti-inflammatory property of arid region honey
[95].
Greek thyme honey-derived monoterpene significant apoptotic activity in PC-3 cells (prostate cancer cells), mediated, at
least in part, through reduction of NF-κB activity and IL-6 secretion [96].
Honey ethyl acetate extract and honey methanol extract The highest inhibition percentages of NO production in RAW264.7 cells
treated with honey extracts after LPS and IFN-γ stimulation were 80%
(4.3 μmol/L of NO) and 40% (16 μmol/L) for honey ethyl acetate extract and
honey methanol extract (100 μg/mL), respectively [97].
Honey bee larva powder exhibits anti-inflammatory activity by decreasing the production of nitric oxide
(NO) and the cytokine level of interleukin-6 (IL-6) in lipopolysaccharide (LPS)-
stimulated RAW 264.7 macrophage [98].
Honey bee (Apis mellifera) venom inhibited lipid accumulation and C/EBPα and PPARγ gene expression during
intermediate and late 3 T3-L1 cell differentiation. It also suppressed gene
expression of pro-inflammatory cytokines (COX-2, iNOS, MCP-1, TNF-α, IL-1β
and IL-6) in LPS-stimulated macrophages, and in co-culture of 3 T3-L1 adipo-
cytes and RAW264.7 macrophages [99].
Honeys produced from Echium plantagineum L decrease NO levels in lipopolysaccharide-stimulated murine macrophage-like
cells (RAW 264.7) up to 40% at concentrations of 0.25 mg/mL [100].
Kelulut honey (KH) KH exerted anti-inflammatory activity in LPS-induced RAW 264.7 cells, where a
significant reduction in NO levels was observed at 1% compared to the un-
treated cells (LPS-induced RAW 264.7 cells) [91].
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of intestinal barrier. These factors include mucus
producing-Goblet cells, antimicrobial peptide-providing
Paneth cells and commensal microflora [107]. The dis-
turbance of these integrated factors by burns, trauma, or
systemic stress dysfunction the gastrointestinal barrier
allowing bacterial endotoxin to translocate and initiate
inflammation [108]. Recently, it has been proposed that
the occurrence of inflammatory gastrointestinal tract
disorders have been strongly associated with systemic in-
flammatory response leading to multi organ dysfunction
and ended up with fatality [109]. Few scientific reports
have examined honey intake against inflammation in
gastrointestinal tract disorders models. For example, ul-
cerative colitis is considered as one of the chronic in-
flammatory gastrointestinal diseases affecting 5–10 per
100,000 [110]. However, supplementing natural Egyptian
honey (1 g/rat) in dextran sodium sulfate-induced ul-
cerative colitis in Wister rats has significantly reduced
IL-1β and IL-6 in the serum while TNF-α, inducible ni-
tric oxide synthase, caspase-3 have been downregulated
in the colonic tissues [86]. Similarly, Turkish natural
honey treatment for seven days was noticed to signifi-
cantly reduce the macroscopic and microscopic lesions
in trinitrobenzene-induced ulcerative colitis in Wister
rat compared to synthetic drugs supplementation.
Surprisingly, nitric oxide was not remarkably reduced
through the same period suggesting that resolving the
inflammatory process in the colonic tissues were not as-
sociated with modulating inflammatory cytokines [73].
Likewise, chronic gastric ulcer in Wister rats feed with
2.5 g/kg of Manuka honey has been alleviated through
promoting anti-inflammatory cytokine IL-10 and minim-
izing pro-inflammatory cytokines TNF-α, IL-1β and IL-6
[72]. The preventive activities of honey against 3% acetic
acid-induced colitis in rodents have been also noted with
high dose (5 g/kg). This prevention of colonic inflammation
accounted for the reduction of systemic pro-inflammatory
cytokines. Using the same above-mentioned dose (5 g/kg)
of Manuka honey, the scores of ulcerative colitis were
reduced [85]. The reduction of inflammatory state after
consuming Italian chestnut honey was studied in
indomethacin-induced gastric in Sprague dawley rats. Two
doses of chestnut honey (1.2 g/kg and 2 g/kg) consumed for
seven days had decreased similarly the ulcer lesions, micro-
vascular permeability, and myeloperoxidase activity of
stomach throughout enhancing the scavenging perform-
ance of free radicals [70]. In fact, although gastro-intestinal
tract pathology retains high potential of developing sys-
temic inflammation through allowing the toxic component
of gut lumen namely, free fatty acids, inflammatory
Table 1 In vivo and in vitro studies on the effect of different types of honey (Continued)
Honey from different floral sources, including Bidens pilosa,
Dimocarpus longan, Litchi chinensis, Citrus maxima, and Aglaia
formosana.
Honey from Bidens pilosa had significantly greater scavenging activities for 1,
1-diphenyl-2-picrylhydrazyl (DPPH·), more reducing power, higher antibacterial
activity against gram-positive and gram-negative bacteria compared to others.
However, B. pilosa honey showed little inhibitory activity against IL-8 secretion,
compared to other honeys [101].
Honey proteins Honey proteins/peptides fractionated by size exclusion chromatography into
five peaks with molecular masses in the range of 2–450 kDa inhibit reactive
oxygen species production in zymosan-activated human neutrophils and mur-
ine macrophages, significantly suppressed the nitric oxide production by LPS-
activated murine macrophages, inhibited the phagocytosis latex bead macro-
phages, did not affect the production of IL-1β; however, TNF-α production
was significantly suppressed [102].
Manuka honey (MH) MH (0.5%) significantly increases the release of CXCL8/IL-8, CCL2/MCP-1,
CCL4/MIP-1β, CCL20/MIP-3α, IL-4, IL-1ra, and FGF-13 while reducing proteinase
3 release in the anti-inflammatory-stimulated models. However, higher dose of
MH (3%) significantly increased the release of TNF-α and CXCL8/IL-8 while re-
ducing the release of all other analytes [103].
Tesco and Manuka honeys Both honeys gave significant protective effect against H2O2-induced DNA
damage in Caco-2 cells, following digestion [43].
Bracatinga (Mimosa scabrella Bentham) honeydew honeys It reduced the nitric oxide secretion as well as the inflammatory mediators:
tumor necrosis factor-alpha, interleukin-6, monocyte chemoattractant protein
1, interleukin-12p70, interferon-gamma and interleukin-10 [104].
Honeys (Manuka, pasture, and jelly bush) All honeys significantly increased the TNF-α, IL-1β and IL-6 release from MM6
cells (and human monocytes) when compared with untreated and artificial-
honey-treated cells. Jelly bush honey significantly induced the maximal release
of each cytokine compared with manuka, pasture or artificial honeys. The ef-
fect of honey on wound healing may in part be related to the stimulation of
inflammatory cytokines from monocytic cells [105].
Manuka honey (MH) A 5.8-kDa component in MH stimulated the production of TNF-α via TLR4
which could improve wound healing [106].
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products of phospholipase A2, proinflammatory cytokines
and damage-associated molecular substrates, to pass
through portal vein and mesenteric lymph, the above-
mentioned studies have assented that honey bioactive com-
pounds contribute positively and significantly towards
gastrointestinal tract homeostasis. However, revealing the
molecular mechanisms of honey bioactive compounds in
gastrointestinal tract disorders is still required.
Inflammatory edema
The inflammatory response of human tissue is associ-
ated usually with the presence of edema specially if the
inflamed tissue targets the skin. The accumulation of
fluid and white blood cells in the injured area are caused
by the secretion of inflammatory cytokines into the
bloodstream. In this context, few studies have tested the
anti-inflammatory activity of honey against inflammatory
edema in skin. The most common inflammatory skin
model used is carrageenan-induced paw edema in rodent
[111]. Feeding rats with Gelam honey (2 g/kg) for seven
days have attenuates the thickness of carrageenan-induced
paw edema along with reducing pro-inflammatory cyto-
kines (TNF-α, IL-6, NO, COX-2, PGE2) comparing with
indomethacin [80]. The same research team has repeated
the study to conclude that Gelam honey effect negatively
on transcription factor NF-κB translocation into nucleus
where IκBα degradation is inhibited [55]. Additionally,
injecting Gelam honey (800mg/kg) intraperitonially into
rats challenged with carrageenan and lipopolysaccharide
suppressed the production of NO and PGE2 leading to a
decrement in paw edema and pain [84]. The previous
findings emphasize the evidence of anti-inflammatory
properties in honey against acute inflammation models.
These preventive activities of honey have been tested in
two different routes of administration (GI and intraperito-
neally) and in different doses.
Cancer associated with inflammation
Chronic inflammation conditions are associated with
elevating various pro-inflammatory cytokines and
Fig. 2 Schematic diagram of the effect of honey on the cytokines in the inflammatory response upon stimuli in a cell. No 1 until 8 in red
denotes the inhibition site of honey. Edited from (Hussein, Mohd Yusoff, Makpol, & Mohd Yusof, [55])
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oxidizing agents at which mutagenicity, toxicity and de-
stabilizing DNA lesions are formed and accumulated
leading to increased cancer risk [59]. Thus, measuring
pro-inflammatory cytokines along with ROS have been
documented in various trials aim to develop promising
natural agent to combat cancer [112]. In this context,
few oncogenic clinical trials have evaluated the inflam-
matory damage after honey application and/or con-
sumption in cancer subjects. Oral mucositis which is
one of complications in advanced cancer stage initiate
an Iranian research team to perform a double-blind
randomized clinical trial for three years continuously
(2011–2013). Seventy-five subjects from Baqiyatallah
University Hospital in Tehran, diagnosed with oral mu-
cositis were enrolled and divided into three groups
treated with either steroid, honey, coffee and honey.
The level of mucositis was reduced significantly after
consuming honey (300 g) every three hours for one
week [113]. The previous findings were comparable
with another clinical trial where the recovery time of
cancer patients diagnosed with chemotherapy-induced
oral mucositis was remarkably decreased after topically
applying honey (15 g/kg) to the affected area of oral
cavity. The previous findings have concluded the at-
tenuation effect of consuming honey on cancer patient
through measuring the grade of mucositis [114]. How-
ever, applying manuka honey to alleviate the radiation-
induced mucositis in neck and head cancer patients
was not statistically significant comparing with control
group [115]. The differences in honeys type and meth-
odology could account for the varied results among the
previous clinical trials. Recently, a meta-analysis study
has concluded that the risk reduction of mucositis in
cancer patients was almost 80% despite of the variation
in methodology among the previous clinical trials
which increase the necessity of conducting further
studies to confirm the published results with more con-
cern on honey dosage and the way of intervention
[116]. Worthy to be mentioned, evaluating the anti-
cancerous effect of honey in the above-mentioned trials
relied on the clinical observation of the inflammatory
damage caused by cancer and/or chemotherapy without
determining the inflammatory cytokines in the sera.
Thus, the mechanistic actions of honey against cancer
still require further investigation on the molecular and
genetic levels.
Since chronic infusion of inflammatory cytokine along
with ROS are released from activated immune cells, angio-
genesis and stroma proliferation induce cancer through
mutations [117]. One epidemiological study has reported
a reduction of colorectal, prostate, and ovarian cancer in-
cidence among subjects taking non-steroidal anti-
inflammatory drugs (NSAIDs) [118]. Further researches
on cancer and inflammation revealed that MAPK and NF-
κB pathways, which are necessary for inflammatory re-
sponse, are imbalanced during oncogenesis [58]. Based on
that, few inflammatory cytokines and related transcription
factors have been determined in multiple cancer models
(in vitro and in vivo) after honey treatment [119]. Gelam
honey in conjunction with ginger crude extract has shown
a chemopreventive ability against colon cancer cell line
(HT-29) through modulating ERK/RAS pathways which
contribute mainly in tumorigenesis [87]. While nitric
oxide elevation has been documented in cancer patients,
the preventive efficiency of Egyptian honey against nitric
oxide released from hepatocellular carcinoma has been
significant comparing with non-treated cells [88]. On the
other hand, IL-6 has been up-regulated in different types
of malignancy but using serial concentrations of Arabic
honey reduce the levels of IL-6 in prostate cancer cell line
[95]. The previous findings were in consistent with Kassi
and his colleagues, where monoterpene, a special phenolic
component in thyme honey, had shown an apoptotic
activity mediated by suppressing NF-κB activity and IL-6
secretion in prostate cancer cell line [96]. Thus, the pro-
hibitory effect of honey against pro-inflammatory cyto-
kines in cancer is mediated by NF-κB which could have a
promising approach in decreasing the change of develop-
ing chronic inflammation. Although honey has a potential
antioxidant activity, the activity of Nrf2, which is a tran-
scription factor responsible for antioxidant enzymes, has
not been determined.
Metabolic and cardiovascular diseases associated with
inflammation
Low-grade inflammation has been strongly associated
with several metabolic changes including, atherogenic
dyslipidemia, hypertension, insulin resistance, and ab-
dominal obesity [120]. The previous metabolic changes
have been noted in most individuals associated with car-
diovascular disease. This study concluded that consum-
ing 75 g of natural honey cause a reduction in LDL-
cholesterol. The reason behind this action is probably
due to high capacity of honey in free radicals scavenging
[121]. Therefore, honey, as it has anti-inflammatory ac-
tivity, may contribute positively to the prevention of
metabolic and cardiovascular diseases particularly in
case honey mixed with other healthy foods. A study con-
ducted on 38 patients and 17 healthy subject consumed
natural honey for 30 days has improved the cardiovascu-
lar risk factors [122]. Comparing with sucrose, 70 g of
daily honey intake has lowered total cholesterol, low-
density lipoprotein cholesterol (LDL-C), triglyceride,
fasting blood glucose and CRP. Surprisingly, experimen-
tal group has recorded a mild reduction in body weight
and fat comparing with control group. The previous
findings have been explained by [51] where subjects of
the study were supplemented with 1.5 g/kg body weight
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natural honey rich in antioxidant. The plasma phenolics
were increased steadily after six hours of honey intake
which illustrated the increased antioxidant activity.
However, hypercholesterolemia subjects have been given
honey for 14 days without improving the serum LDL
concentrations [121]. In the previous clinical trial, the
subjects have been chosen without differentiating
whether they have been taking statins or not. Likewise,
the TG, LDL and glucose concentrations have not been
changed in impaired glucose intolerant individuals com-
pared with glucose tolerant group after consuming 50 g
of honey for two weeks [122]. Exclusively, Dutch Gold
honey company has gifted two different clinical trials
[51, 123], but their results have been totally controver-
sial. Schramm and his colleagues [51] have confirmed
that Dutch gold honey increased the antioxidant activity
in healthy subjects while Raatz et al. [123] reported that
lipid profile, inflammatory cytokine and insulin sensitiv-
ity did not improve in glucose tolerant post-treatment
with Dutch Gold honey. The recently previous research
has concluded that honey has no effect on improving
glycemia and insulin sensitivity including inflammatory
cytokines (IL-6). To emphasize, the glycosylated
hemoglobin has been increased in diabetic type 2 pa-
tients post honey intervention for eight weeks continu-
ously which subsequently could develop cardiovascular
diseases [124]. The paradox results of above-mentioned
trials may be attributed to various factors: the small
number of recruited subjects, type of honey and the dur-
ation of intervention. Thus, further clinical trials with
controlled conditions should be taken into consideration
to facilitate filling the gaps among other scientific re-
ports. In vivo studies using diabetic rats’ model have
found that Tualang or Nigerian honey treatment im-
prove the glycemia and dyslipidemia [75]. Based on that,
the component of tropical honeys might have high con-
centration of bioactive compound namely, polyphenols
as honeybees expose to a variety of botanical flora as
well as the warmth weather. In addition, honey bee has
been thought to simulate the characteristics of diverse
enzyme inhibitors including, α-glucosidase inhibitors, in-
sulin secretagogues, dipeptidyl peptidase-4 inhibitors
and anti-obesity drug [125]. Overall, human and animal
studies which are subjected to demonstrate the benefi-
cial effect of honey particularly regarding metabolic and
cardiovascular diseases are still insufficient to draw a
conclusion.
Gut microbiota associated with inflammation
A growing body of evidence has indicated that gut
microbiome influence strongly not only energy homeo-
stasis but also the inflammatory status in human body.
Since the number of gut microbiome is at least 10-fold
more than the human body cells, therefore, this large
pool of cells provides a significant biological and meta-
bolic function which could not be performed by human
cells [126]. The immunological functions of gut micro-
biota in human body are present by developing and
maintaining the mucosal immune system, sheltering
against pathogen invasion and preserving the barrier in-
tegrity of gastrointestinal tract [127]. In the presence of
LPS-producing bacteria in colon along with low levels of
beneficial bacteria, gut permeability is increased leading
to a higher influx of LPS in plasma, so-called metabolic
endotoxemia. In accordance with the previous hypoth-
esis, linking LPS with Toll-like receptor 4 on mono-
nuclear cells may trigger low grade of inflammation
which subsequently lead to chronic diseases [128]. There
are few supernatural foods that possess a symbiotic char-
acteristic which is a combination of prebiotic carbohy-
drate with specific probiotic strain [129]. In this context,
the prebiotic oligosaccharide and antibacterial com-
pounds existed in honey had been elaborated. Manuka
honey has a potentially beneficial efficacy in growing
specific types of probiotics (Lactobacillus reuteri, Lacto-
bacillus rhamnosus, and Bifidobacterium lactis) and inhi-
biting other pathogens (Escherichia coli, Salmonella
typhimurium, and Staphylococcus aureus). Honey has
shown potent probiotic properties when it is incubated,
at maximum levels, with milk and/or selective growth
media. Thus, pathogenic and intestinal microbes have
been inhibited after the treatment [130]. In the light of
previous evidences, honey can promote the growth of se-
lective bacteria namely, Lactobacillus and Bifidobacter-
ium genera over other unfavorable microbes. Recently, a
new research team has found that encapsulated honey
enhances the survivability of Bifidobacterium strains,
well-known probiotics, in gastrointestinal simulation
comparing with sodium encapsulation [131]. Investi-
gating the probiotic efficacy of honey-rich diet on
animal model or human could probably confirm the
in vitro results by which understanding the healthy
beneficial activity of honey against inflammation is
potential. Furthermore, feeding albino rats with two
gram of natural honey per day for 6 weeks altered the
lactic acid bacteria number to be higher than undesir-
able microbes [132]. The combination of prebiotic
and probiotic (synbiotic) activity of Manuka honey is
applied by inhibiting the Helicobacter pylori, a bacter-
ium that cause stomach ulcer, and by supporting the
growth of Lactobacillus reuteri. More deeply, the two
antibacterial components, reuterin from Lactobacillus
reuteri and methylglyoxal from Manuka honey have a
structural similarity [133]. In this prospective, each
type of honey probably could support special strain of
beneficial bacteria and thus, in vivo, and clinical trials
may evaluate and establish the potential prebiotic effi-
cacy of honey oligosaccharide.
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Honey consumption and contradiction
Most often nutritionist and/or physicians tended to alert
individuals from consuming high amount of honey and
its potential health hazards, however, the ancient usage
of honey and the recent discoveries of biological com-
pounds in honey have changed this notice and support
the research on its effect on oxidative stress, wound
healing, ageing, inflammation, cancer, diabetes, bacterial
growth and atherosclerosis. Despite of the mounting evi-
dence of healthy-honey roles, precautions from its con-
sumption are still required. In this sense, honey might
contain various of contaminants including pesticides, an-
tibiotics, heavy metals, and other toxic materials which
is probably added either through occasional exposure to
environmental hazards or through beekeepers to control
honeybee maladies. These chemical materials have been
proven to cause a seriously unexpected consequence. In
addition, the pathogenic contamination with Clostridium
botulinum has been considered as a toxic factor, particu-
larly for infants who are below 12months. For this rea-
son, honey should be sterilized with gamma irradiation
to reduce the infectious concern without any loss of nat-
ural honey therapeutics [134]. Moreover, the presence of
allergens, which is derived from bee glands has been ac-
cused to stimulate allergy despite of its rare incidence.
However, a case report has been published recently de-
scribing that consuming honey and foods-contain honey
has caused anaphylaxis [135]. In terms of using honey as
topical application, there are various adverse effects that
are needed to be controlled. A transient burning sensa-
tion has been noticed in wounded patients while dia-
betes patients may exhibit a high blood glucose along
with tissue dehydration. Further, the limited data about
honey should be a stimulator for further studies to
Fig. 3 The absorption of honey-bioactive compounds and the proposed mechanism of their therapeutic actions against inflammation
Ranneh et al. BMC Complementary Medicine and Therapies           (2021) 21:30 Page 12 of 17
provide detailed results about the exact content of bio-
active compounds, particularly polyphenols. More
deeply, the above mentioned have mainly attributed the
healthy benefits of honey to its polyphenols content.
Therefore, honey-producers are encouraged to label the
phenolic content on their honey products.
Conclusion
Honey consumption has high nutritional and therapeutic
values. The phytochemical compounds in honey depends
mainly on various factors, floral source, honey type, con-
centration, and bee type. These factors affect the bio-
logical activities of each types of honey. Basically, most
therapeutic properties of honey come from the polyphe-
nols. The aforementioned studies confirmed that honey
polyphenols have high bioavailability value compared to
other functional foods due to various reasons; 1) lack of
food matrix in honey composition, 2) lack of food inter-
actions, and 3) honey polyphenols are not exposed to
any chemical reaction such as extraction or decoction
which could affect their quality. Thus, targeted tissues
benefit from the honey’s pharmacological and preventive
actions which modulate the inflammatory cytokines
functions and ultimately reduce the severity of chronic
inflammatory diseases (Fig. 3). However, the molecular
mechanisms of polyphenols rich in honey are not fully
illustrated. For this reason, further investigations are still
needed in the nutrigenomics analysis to fully elucidate
the genome-wide influences of honey and patterns of
global gene expression, protein expression, intracellular
signaling pathways, and metabolite production in re-
sponse to particular compounds. Finally, examine the ef-
fects of honey on the gene expression profiling with
special emphasis on human intervention trials, ideally
with large-scale randomized placebo-controlled studies,
in order to yield important insights into their prophylac-
tic and therapeutic uses, as well as develop effective
strategies for alleviating chronic inflammatory diseases.
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